Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Clinical trial NCT00382200 · COMPLETED
Trial details
- NCT number
- NCT00382200
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2023-01-05
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.